ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 117 filers reported holding ENDOCYTE INC in Q2 2018. The put-call ratio across all filers is 1.51 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,766,000 | +28.6% | 99,433 | -0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,373,000 | +600.5% | 99,468 | +30.1% | 0.00% | – |
| Q1 2017 | $196,000 | -2.0% | 76,459 | -2.3% | 0.00% | – |
| Q4 2016 | $200,000 | -19.7% | 78,259 | -2.7% | 0.00% | -100.0% |
| Q3 2016 | $249,000 | -2.7% | 80,459 | +0.9% | 0.00% | 0.0% |
| Q2 2016 | $256,000 | +2.4% | 79,759 | -1.1% | 0.00% | 0.0% |
| Q1 2016 | $250,000 | -10.4% | 80,659 | +15.9% | 0.00% | 0.0% |
| Q4 2015 | $279,000 | -10.9% | 69,607 | +1.8% | 0.00% | 0.0% |
| Q3 2015 | $313,000 | -12.1% | 68,360 | -0.3% | 0.00% | 0.0% |
| Q2 2015 | $356,000 | -15.6% | 68,560 | +1.7% | 0.00% | 0.0% |
| Q1 2015 | $422,000 | -2.3% | 67,429 | -1.9% | 0.00% | 0.0% |
| Q4 2014 | $432,000 | +3.8% | 68,729 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $416,000 | -6.7% | 68,437 | +1.2% | 0.00% | 0.0% |
| Q2 2014 | $446,000 | -66.2% | 67,649 | +22.0% | 0.00% | -66.7% |
| Q1 2014 | $1,320,000 | +124.5% | 55,449 | +0.7% | 0.00% | +50.0% |
| Q4 2013 | $588,000 | -19.6% | 55,049 | +0.4% | 0.00% | 0.0% |
| Q3 2013 | $731,000 | +4.9% | 54,849 | +3.3% | 0.00% | 0.0% |
| Q2 2013 | $697,000 | +9.1% | 53,091 | +3.4% | 0.00% | 0.0% |
| Q1 2013 | $639,000 | – | 51,331 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|